Joan K. Decelie-Germana

Joan K. Decelie-Germana

Pediatric Pulmonology

410 Lakeville Road
Suite 305
Lake Success, NY 11042

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Evolution of the New York State Cystic Fibrosis Newborn Screening Algorithm: Two Decades of Experience.

Evolution of the New York State Cystic Fibrosis Newborn Screening Algorithm: Two Decades of Experience.

Journal: Pediatric pulmonology

Published: January 31, 2026

Transforming Care Models in Cystic Fibrosis: A Review.

Transforming Care Models in Cystic Fibrosis: A Review.

Journal: Healthcare (Basel, Switzerland)

Published: August 20, 2025

Characterization of 223 infants with CFTR-related metabolic syndrome/Cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID) identified during the first three years of newborn screening via IRT-DNA-SEQ in New York State.

Characterization of 223 infants with CFTR-related metabolic syndrome/Cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID) identified during the first three years of newborn screening via IRT-DNA-SEQ in New York State.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: April 08, 2024

Variability in evaluation and follow-up of newborns with CRMS/CFSPID in New York State.

Variability in evaluation and follow-up of newborns with CRMS/CFSPID in New York State.

Journal: Pediatric pulmonology

Published: August 31, 2023

Genetic counseling access and service delivery in New York State is variable for parents of infants with complex CFTR genotypes conferring uncertain phenotypes.

Genetic counseling access and service delivery in New York State is variable for parents of infants with complex CFTR genotypes conferring uncertain phenotypes.

Journal: Pediatric pulmonology

Published: August 31, 2023

The impact of elexacaftor/tezacaftor/ivacaftor on cystic fibrosis health-related quality of life and decision-making about daily treatment regimens: a mixed methods exploratory study.

The impact of elexacaftor/tezacaftor/ivacaftor on cystic fibrosis health-related quality of life and decision-making about daily treatment regimens: a mixed methods exploratory study.

Journal: Therapeutic advances in chronic disease

Published: July 12, 2023

Diagnostic and Communication Challenges in Cystic Fibrosis Newborn Screening.

Diagnostic and Communication Challenges in Cystic Fibrosis Newborn Screening.

Journal: Life (Basel, Switzerland)

Published: July 07, 2023

Reproductive Counseling and Care in Cystic Fibrosis: A Multidisciplinary Approach for a New Therapeutic Era.

Reproductive Counseling and Care in Cystic Fibrosis: A Multidisciplinary Approach for a New Therapeutic Era.

Journal: Life (Basel, Switzerland)

Published: May 19, 2023

The clinical impact of the Covid-19 pandemic first wave on patients with cystic fibrosis in New York.

The clinical impact of the Covid-19 pandemic first wave on patients with cystic fibrosis in New York.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: July 19, 2021

Clinical Sensitivity of Cystic Fibrosis Mutation Panels in a Diverse Population.

Clinical Sensitivity of Cystic Fibrosis Mutation Panels in a Diverse Population.

Journal: Human mutation

Published: August 10, 2015

Utility of a very high IRT/No mutation referral category in cystic fibrosis newborn screening.

Utility of a very high IRT/No mutation referral category in cystic fibrosis newborn screening.

Journal: Pediatric pulmonology

Published: November 13, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026